BioLargo, Inc.
BLGO
$0.202
-$0.0027-1.32%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.16M | -1.01M | -537.00K | -441.00K | -410.00K |
| Total Depreciation and Amortization | 85.00K | 67.00K | 68.00K | 60.00K | 41.00K |
| Total Amortization of Deferred Charges | 28.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.00K | 217.00K | -200.00K | 203.00K | 259.00K |
| Change in Net Operating Assets | -723.00K | -1.19M | -951.00K | 27.00K | 591.00K |
| Cash from Operations | -1.83M | -1.92M | -1.62M | -151.00K | 481.00K |
| Capital Expenditure | -- | 25.00K | -39.00K | -358.00K | -863.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -82.00K | -- | -- | -- |
| Cash from Investing | -- | -57.00K | -39.00K | -358.00K | -863.00K |
| Total Debt Issued | 590.00K | 864.00K | -- | -- | -- |
| Total Debt Repaid | -4.00K | -2.00K | -4.00K | -3.00K | -5.00K |
| Issuance of Common Stock | 295.00K | -- | 768.00K | 1.00M | 1.09M |
| Repurchase of Common Stock | -- | -1.28M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.00K | 2.01M | -- | -- | -- |
| Cash from Financing | 866.00K | 1.59M | 764.00K | 999.00K | 1.08M |
| Foreign Exchange rate Adjustments | -20.00K | 47.00K | 12.00K | -61.00K | 96.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -984.00K | -334.00K | -883.00K | 429.00K | 797.00K |